Skip to main content
Quest Diagnostics

Laboratory Testing in the Diagnosis and Management of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)

Date: Friday, Jan 22, 2016

Description: Martin J. Bergman, MD discusses the seriousness of a diagnosis of rheumatoid arthritis for patients who are afflicted and the appropriate use and limitations of laboratory testing in the diagnosis and monitoring for rheumatoid disease activity.

Learning Objectives:

  • Understand the role of laboratory testing in the diagnosis of RA and PsA
  • Recognize proper lab screening prior to the initiation of Disease Modifying Antirheumatic Drugs (DMARDS) or biologic therapy
  • Discuss the role of lab testing in the monitoring of disease activity and medication toxicities.

Related content

On-Demand Webinar
Mutated Citrullinated Vimentin Antibody as an Alternative Marker for RA
Test FAQ
Tests for Autoimmune Diseases

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.